Bradley Merrill Thompson Quoted in “23andMe to Open Database to External Researchers After Securing NIH Grant”


Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the Washington, DC office, was quoted in an article titled "23andMe to Open Database to External Researchers After Securing NIH Grant"

Following is an excerpt:

While Google ($GOOG)-backed personal genetics startup 23andMe is still working through its disagreements with the FDA, the company has impressed another part of the federal machine enough to win funding. And having snagged the $1.4 million National Institutes of Health grant, 23andMe plans to open up its trove of genotype and phenotype data to partners in industry and academia.

While the grant helps to strengthen and validate 23andMe's research business, observers have warned against inferring anything about the startup's relationship with FDA. "It is a common everyday occurrence that one federal agency might invest in a new technology that another federal agency views with skepticism. So the NIH investment means nothing with regard to FDA," Epstein Becker Green attorney Brad Thompson told VentureBeat.